A transplacental carcinogenicity bioassay in CD-1 mice with zidovudine

Fundamental and Applied Toxicology

Volumn 38, Issue 2, 1997, Pages 195-198

  Ayers, Kenneth M ^a   Torrey, Carla E ^a   Reynolds, David J ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; LONG TERM EXPOSURE; MACROCYTIC ANEMIA; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLACENTAL TRANSFER; SQUAMOUS CELL CARCINOMA; VAGINA CARCINOMA;

ANIMALIA;

EID: 85033515872     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1997.2342     Document Type: Article

References (12)

1. Ali M. W. Exact versus asymptotic tests of trend of tumor prevalence in tumorigenicity experiments. A comparison of p-values for small frequency of tumors. Drug Inform. J. 24:1990;727-737.
2. Ayers K. M., Clive D., Tucker W. E. Jr., Hajian G., de Miranda P. Nonclinical toxicology studies with zidovudine: Genetic toxicity tests and carcinogenicity bioassays in mice and rats. Fundam. Appl. Toxicol. 32:1996;148-158.
3. Connor E. M., Sperling R. S., Gelber R., Kisalev P., Scott G., O'Sullivan M. J., Van Dyke R., Bey M., Shearer W., Jacobson R. L. Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment. N. Engl. J. Med. 331:1995;1173-1180.
4. Dinse G. E., Lagakos S. W. Regression analysis of tumor prevalence data. J. R. Stat. Soc. Ser. C (Appl. Stat.). 32:1983;236-241.
5. Gart J. J., Krewski D., Lee P. N., Tarone R. E., Wahrendorf J. Statistical methods in cancer research. The Design and Analysis of Long Term Animal Experiments. 1986;Oxford Univ. Press, London. p. 219-.
6. Olivero O. A., Beland F. A., Fullerton N. F., Poirier M. C. Vaginal epithelial damage and expression of preneoplastic markers in mice during chronic dosing with tumorigenic levels of AZT. Cancer Res. 54:1994;6235-6242.
7. Physicians' Desk Reference. 1996;. p. 1162-1163.
8. Rowe P. M. US expert panel reaffirms benefit of perinatal zidovudine. Lancet. 349:1996;258.
9. Ruprecht R. M., Sharpe A. H., Jaenisch R., Trites D. Analysis of 3′-azido-3′-deoxythymidine levels in tissues and milk by isocratic high-performance liquid chromatography. J. Chromatogr. 528:1990;371-383.
10. Tadapalli S., Puckett L., Jeal S., Kanics L., Quinn R. Differential assay of zidovudine and its glucuronide metabolite in serum and urine with a radioimmunoassay kit. Clin. Chem. 36:1990;897-900.
11. Thakur A. K., Berry K. J., Mielke P. W. Jr. A FORTRAN program for testing trend and homogeneity in proportions. Comput. Biomed. Res. 19:1985;229-233.
12. Thomas D. G., Breslow N., Gart J. J. Trend and homogeneity analyses of proportions and life table data. Comput. Biomed. Res. 10:1977;373-381.